<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.timesreporterafrica.com/article/912248900-government-leaders-to-accelerate-the-power-of-social-innovation-to-tackle-societal-economic-and-environmental-crises</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T10:36:32+00:00</news:publication_date>
        <news:title>Government leaders to accelerate the power of social innovation to tackle societal, economic and environmental crises</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912603310-tango-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-highlights</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T20:07:25+00:00</news:publication_date>
        <news:title>Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d6e37a27-2e33-43bb-ae05-bfb0dedbf190/small/tango-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912602348-spero-therapeutics-announces-first-quarter-2026-operating-results-and-provides-business-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T20:05:00+00:00</news:publication_date>
        <news:title>Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/aad6f25c-1793-4870-a611-84ea3f25fed3/small/spero-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912602284-allogene-therapeutics-reports-first-quarter-2026-financial-results-and-business-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T20:02:00+00:00</news:publication_date>
        <news:title>Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912602885-macrogenics-reports-first-quarter-2026-financial-results-and-highlights-business-transformation</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T20:01:00+00:00</news:publication_date>
        <news:title>MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9b9481ff-ca9f-4a5a-aa38-0ff57a087856/small/macrogenics-logo-rgb-fullcolor-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912603264-medicenna-announces-the-launch-of-a-marketed-public-offering-of-securities</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T20:01:00+00:00</news:publication_date>
        <news:title>Medicenna Announces the Launch of a Marketed Public Offering of Securities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912603150-us-critical-materials-and-bayan-mining-and-minerals-announce-strategic-collaboration-to-advance-rare-earth-processing-capability-utilizing-colorado</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T19:38:58+00:00</news:publication_date>
        <news:title>US Critical Materials and Bayan Mining and Minerals Announce Strategic Collaboration to Advance Rare Earth Processing Capability Utilizing Colorado School of Mines Technology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7f970dcc-d2cb-4793-8e3b-8b0f58220dad/small/us-critical-materials-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912578578-zoomex-x-space-zusammenfassung-mit-ollie-bearman-und-krypto-experten</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T18:28:18+00:00</news:publication_date>
        <news:title>Zoomex X Space-Zusammenfassung mit Ollie Bearman und Krypto-Experten</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/9e22b44f-557d-4994-be0b-7430e1b6bce8/medium/zoomex-x-space-zusammenfassung-mit-ollie-bearman-und-krypto.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912578590-zoomex-x-space-recap-with-ollie-bearman-and-crypto-kols</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T18:28:18+00:00</news:publication_date>
        <news:title>Zoomex X Space Recap With Ollie Bearman and Crypto KOLs</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/9e22b44f-557d-4994-be0b-7430e1b6bce8/medium/zoomex-x-space-recap-with-ollie-bearman-and-crypto-kols.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912578598-resumen-de-zoomex-x-space-con-ollie-bearman-y-kols-del-mundo-cripto</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T18:28:18+00:00</news:publication_date>
        <news:title>Resumen de Zoomex X Space con Ollie Bearman y KOLs del mundo cripto</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/9e22b44f-557d-4994-be0b-7430e1b6bce8/medium/resumen-de-zoomex-x-space-con-ollie-bearman-y-kols-del-mundo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912578607-r-capitulatif-de-zoomex-x-space-avec-ollie-bearman-et-les-kol-crypto</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T18:28:18+00:00</news:publication_date>
        <news:title>Récapitulatif de Zoomex X Space avec Ollie Bearman et les KOL crypto</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/9e22b44f-557d-4994-be0b-7430e1b6bce8/medium/recapitulatif-de-zoomex-x-space-avec-ollie-bearman-et-les-ko.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/911928054-xs-com-reconhecida-como-melhor-corretora-de-cfds-em-evento-da-rankia-no-peru</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T04:33:59+00:00</news:publication_date>
        <news:title>XS.com Reconhecida como “Melhor Corretora de CFDs” em Evento da Rankia no Peru</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24855055-13-05-rankia-latam-peru-post-500x500.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912221940-world-bank-hosted-fund-opens-163m-grants-program-to-bolster-food-security-for-world-s-poorest-farmers</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T04:01:00+00:00</news:publication_date>
        <news:title>World Bank-hosted fund opens $163m grants program to bolster food security for world’s poorest farmers</news:title>
      </news:news>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912533906-panoro-minerals-ltd-announces-closing-of-upsized-brokered-life-offering-for-gross-proceeds-of-c-21-000-000</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T14:17:21+00:00</news:publication_date>
        <news:title>Panoro Minerals Ltd. Announces Closing of Upsized Brokered LIFE Offering for Gross Proceeds of C$21,000,000</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c4997824-e4b5-434d-936e-0b858a625815/small/picture1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912533301-sapu-nano-announces-first-patient-dosed-in-phase-1b-trial-of-sapu003-an-intravenous-deciparticle-formulation-of-everolimus</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T14:00:00+00:00</news:publication_date>
        <news:title>Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912533554-noted-vaccine-researchers-u-ur-ahin-and-zlem-t-reci-awarded-sabin-vaccine-institute-s-albert-b-sabin-gold-medal-genomic-scientist-senjuti-saha-of</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T13:41:04+00:00</news:publication_date>
        <news:title>Noted Vaccine Researchers Uğur Şahin and Özlem Türeci Awarded Sabin Vaccine Institute’s Albert B. Sabin Gold Medal; Genomic Scientist Senjuti Saha of Bangladesh Receives Rising Star Award</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4edff3d3-064b-408f-a6fb-b2d48107b8de/medium/2026-sabin-rising-star-gold-medal-awardees.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912533516-onconetix-reports-q1-2026-progress-at-proteomedix-ag-including-two-new-peer-reviewed-publications-and-initiation-of-u-s-validation-study</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T13:25:00+00:00</news:publication_date>
        <news:title>Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4824d51d-2ecb-4f49-8b75-fe9b920e7b1c/small/onconetix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912533408-biofrontera-launches-second-annual-hats-on-campaign-to-raise-awareness-of-actinic-keratosis</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T13:00:00+00:00</news:publication_date>
        <news:title>Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4af5197e-340e-4307-892b-382a1d29ae45/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912532759-rectify-pharmaceuticals-to-present-preclinical-data-on-new-dual-targeted-abcb4-bsep-positive-functional-modulator-at-easl-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T12:30:00+00:00</news:publication_date>
        <news:title>Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bdac6aa0-18b4-4330-98a1-e9673a671b69/small/rectify-logo-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912532864-fate-therapeutics-reports-first-quarter-2026-financial-results-and-business-updates</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T12:30:00+00:00</news:publication_date>
        <news:title>Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912533092-lite-strategy-reports-fiscal-2026-third-quarter-results</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T12:30:00+00:00</news:publication_date>
        <news:title>Lite Strategy Reports Fiscal 2026 Third Quarter Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0cc6e77-6ce2-4afa-adb0-13a8e61c35fb/small/lite-strategy-logo-dark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912533331-globex-options-carp-fluorspar-property-in-nevada-to-evion-group-nl-of-australia</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T12:30:00+00:00</news:publication_date>
        <news:title>Globex Options Carp Fluorspar Property in Nevada to Evion Group NL of Australia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9e3937f9-cc8e-40a6-a88c-bc44753b3314/small/globex-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912508695-century-therapeutics-reports-first-quarter-financial-results-and-business-updates</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T12:00:00+00:00</news:publication_date>
        <news:title>Century Therapeutics Reports First Quarter Financial Results and Business Updates </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912508743-oryzon-to-present-updated-positive-clinical-data-for-iadademstat-in-acute-myeloid-leukemia-at-eha-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T12:00:00+00:00</news:publication_date>
        <news:title>ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/56e13ce4-e7d9-45ee-85e9-26feec9b7c6f/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912508938-zusduri-median-duration-of-response-still-not-reached-with-64-5-36-month-duration-of-response-in-the-pivotal-envision-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T12:00:00+00:00</news:publication_date>
        <news:title>ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b4e2813-5822-438f-a0d8-1a2c99628858/small/urogen-logo2-r-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912509575-sapu-nano-announces-first-patient-dosed-in-phase-1b-trial-of-sapu003-an-intravenous-deciparticle-formulation-of-everolimus</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T12:00:00+00:00</news:publication_date>
        <news:title>Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb58c424-43e8-41dc-bbec-f53dc94cfc28/small/logo-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912509579-sapu-nano-sapu003-deciparticle-1b</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T12:00:00+00:00</news:publication_date>
        <news:title>Sapu Nano 宣布 Sapu003 (基于 Deciparticle™ 技术的依维莫司静脉注射剂型) 1b 期临床试验完成首例患者给药</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb58c424-43e8-41dc-bbec-f53dc94cfc28/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912509587-sapu-nano-deciparticle-sapu003-1b</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T12:00:00+00:00</news:publication_date>
        <news:title>Sapu Nano 宣佈旗下靜脈注射 Deciparticle™ 配方依維莫司 —— Sapu003 的 1b 期試驗，已為首位患者完成給藥</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb58c424-43e8-41dc-bbec-f53dc94cfc28/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912508944-pyxis-oncology-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T11:30:00+00:00</news:publication_date>
        <news:title>Pyxis Oncology to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912508990-altimmune-announces-first-quarter-2026-financial-results-and-business-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T11:30:00+00:00</news:publication_date>
        <news:title>Altimmune Announces First Quarter 2026 Financial Results and Business Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912509177-hengrui-pharma-and-kailera-therapeutics-announce-clinical-data-presentations-at-the-american-diabetes-association-86th-scientific-sessions</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T11:30:00+00:00</news:publication_date>
        <news:title>Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912509066-altimmune-to-present-results-of-pemvidutide-in-mash-in-an-oral-presentation-and-multiple-poster-presentations-at-easl-congress-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T11:15:00+00:00</news:publication_date>
        <news:title>Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912509644-milestone-pharmaceuticals-announces-first-quarter-2026-financial-results-and-provides-corporate-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T11:11:06+00:00</news:publication_date>
        <news:title>Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912508724-pds-biotech-reports-first-quarter-2026-financial-results-and-provides-clinical-programs-and-corporate-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T11:00:00+00:00</news:publication_date>
        <news:title>PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e2e7d124-dbd4-4140-9cc5-449d3488a902/small/pds-biotech-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912509158-verano-submits-dea-registration-applications-for-state-licensed-medical-cannabis-businesses-following-landmark-federal-rescheduling-order</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T11:00:00+00:00</news:publication_date>
        <news:title>Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/18f2c9e0-d960-440b-a51f-b7d7ea7c9e08/small/verano-company-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912509163-biocryst-to-present-new-real-world-evidence-underscoring-the-ongoing-burden-of-pediatric-hereditary-angioedema-at-ispor-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T11:00:00+00:00</news:publication_date>
        <news:title>BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912509608-andera-partners-leads-20-million-series-d-financing-in-rivermark-medical</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T11:00:00+00:00</news:publication_date>
        <news:title>Andera Partners Leads $20 Million Series D Financing in Rivermark Medical</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/84827000-8d17-4bc9-9829-3a4706db49ea/small/andera-logo-rvb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912509105-zenas-biopharma-announces-first-subject-dosed-in-phase-1-clinical-trial-of-zb021-a-novel-potentially-best-in-class-oral-il-17aa-af-inhibitor</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T10:50:00+00:00</news:publication_date>
        <news:title>Zenas BioPharma Announces First Subject Dosed in Phase 1 Clinical Trial of ZB021, a Novel, Potentially Best-in-Class Oral IL-17AA/AF Inhibitor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912508708-veru-reports-fiscal-2026-second-quarter-financial-results-and-phase-2b-plateau-clinical-trial-progress</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T10:30:00+00:00</news:publication_date>
        <news:title>Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c96f1a7-e104-47d4-8011-8c19496681c2/small/final-veruinclogo-rgb-300dpi-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912508714-aprea-therapeutics-reports-first-quarter-2026-financial-results-and-provides-a-corporate-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T10:30:00+00:00</news:publication_date>
        <news:title>Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912483853-zymeworks-announces-participation-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T10:00:00+00:00</news:publication_date>
        <news:title>Zymeworks Announces Participation in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912483864-titan-mining-enters-into-cooperation-agreement-with-teck-s-trail-operations-to-evaluate-germanium-recovery-from-existing-mine-waste-streams</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T10:00:00+00:00</news:publication_date>
        <news:title>Titan Mining Enters into Cooperation Agreement with Teck’s Trail Operations to Evaluate Germanium Recovery from Existing Mine Waste Streams</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/aa21218a-f0e4-4fe8-91f3-f92bacda93cb/small/titan-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912483898-zenas-biopharma-reports-first-quarter-2026-financial-results-and-provides-corporate-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T10:00:00+00:00</news:publication_date>
        <news:title>Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912483913-mexc-launches-spot-grid-trading-to-support-automated-strategy-execution</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T10:00:00+00:00</news:publication_date>
        <news:title>MEXC Launches Spot Grid Trading to Support Automated Strategy Execution</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/523e541e-1c09-47fd-a1f6-e1509e15d030/medium/mexc-launches-spot-grid-trading-to-support-automated-strateg.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912483914-equinox-gold-and-orla-mining-combine-to-create-north-america-s-new-senior-gold-producer-built-to-grow-built-to-last</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T10:00:00+00:00</news:publication_date>
        <news:title>Equinox Gold and Orla Mining Combine to Create North America’s New Senior Gold Producer: Built to Grow, Built to Last</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/322c1a7d-5c3e-4a91-8e8e-4842b3dafa6b/small/eqx-logo-300dpi-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912483773-heparegenix-to-present-interim-phase-1b-data-for-darizmetinib-hrx215-in-a-late-breaking-oral-presentation-at-the-european-association-for-the-study</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T09:00:00+00:00</news:publication_date>
        <news:title>HepaRegeniX to Present Interim Phase 1b Data for Darizmetinib (HRX215) in a Late-Breaking Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/13819f7b-65d3-4e76-bb03-104b2a3dbb0d/small/heparegenix-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912464785-iux-publishes-gold-market-insight-on-volatility-trends-and-user-engagement-in-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T08:00:00+00:00</news:publication_date>
        <news:title>IUX Publishes Gold Market Insight on Volatility Trends and User Engagement in 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2b7d55e6-113a-4b45-b34d-c764e05e74e1/medium/picture-1.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912275907-newsmatics-launches-journalists-wanted-initiative-to-amplify-credible-journalism-and-expand-audience-reach</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T19:00:00+00:00</news:publication_date>
        <news:title>Newsmatics Launches &#39;Journalists Wanted&#39; Initiative to Amplify Credible Journalism and Expand Audience Reach</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/785401-affinity-group-publishing-logo-720x720.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912446091-aligos-therapeutics-announces-ten-abstracts-accepted-for-presentation-at-the-easl-congress-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T06:05:00+00:00</news:publication_date>
        <news:title>Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/03ffbe89-c47f-4f83-b51f-f13a572e2cd1/small/aligos-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912446071-q1-2026-operational-and-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T06:00:00+00:00</news:publication_date>
        <news:title>Q1 2026 Operational and Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/339067de-ff2d-48df-b28a-e34eb4ae308c/small/amaroq-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912446072-uppgj-r-1-rsfj-r-ungs-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T06:00:00+00:00</news:publication_date>
        <news:title>Uppgjör 1. ársfjórðungs 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/339067de-ff2d-48df-b28a-e34eb4ae308c/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912260178-cimmyt-receives-2025-al-sumait-prize-for-african-development-recognizing-decades-of-science-for-food-security</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T15:38:02+00:00</news:publication_date>
        <news:title>CIMMYT Receives 2025 Al-Sumait Prize for African Development, Recognizing Decades of Science for Food Security</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24854268-al-sumait-prize-2025-1080x1080.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912376343-interim-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-13T00:06:35+00:00</news:publication_date>
        <news:title>Interim Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ac515ff9-d764-4059-82a6-74a5b8004725/small/paladin-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912376302-titan-mining-delivers-22-revenue-growth-and-expands-u-s-critical-minerals-platform-with-graphite-production</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T23:30:00+00:00</news:publication_date>
        <news:title>Titan Mining Delivers 22% Revenue Growth and Expands U.S. Critical Minerals Platform with Graphite Production</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/aa21218a-f0e4-4fe8-91f3-f92bacda93cb/small/titan-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912351771-cosciens-biopharma-inc-reports-q1-2026-results</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T21:05:00+00:00</news:publication_date>
        <news:title>COSCIENS Biopharma Inc. Reports Q1 2026 Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/703faafa-78e2-4d67-be2a-457eb4f57340/small/picture2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912191873-looking-for-the-china-best-plasma-cutting-and-welding-consumables-manufacturer-discover-suchen-s-certified-solutions</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T09:01:18+00:00</news:publication_date>
        <news:title>Looking for the China Best plasma cutting and welding consumables Manufacturer? Discover Suchen’s Certified Solutions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24853895-china-leading-plasma-cutting-an-650x552.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912350656-belo-sun-to-commence-technical-studies-on-volta-grande-gold-project</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T21:00:00+00:00</news:publication_date>
        <news:title>Belo Sun to Commence Technical Studies on Volta Grande Gold Project</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b806d8fd-afcc-4e23-a564-25fa51788320/small/belosun-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912351138-crescent-biopharma-announces-grants-of-inducement-awards</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:30:00+00:00</news:publication_date>
        <news:title>Crescent Biopharma Announces Grants of Inducement Awards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912327817-orchestra-biomed-reports-first-quarter-2026-financial-results-and-highlights-recent-business-updates</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:18:12+00:00</news:publication_date>
        <news:title>Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912350573-palisade-bio-reports-first-quarter-2026-financial-results-and-highlights-continued-clinical-progress-of-pali-2108</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:15:00+00:00</news:publication_date>
        <news:title>Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0beaede8-1c7c-4f77-84a7-b1efd54c343c/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912327210-neumora-therapeutics-to-participate-in-2026-rbc-capital-markets-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:05:00+00:00</news:publication_date>
        <news:title>Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912327283-pharvaris-reports-first-quarter-2026-financial-results-and-provides-business-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:05:00+00:00</news:publication_date>
        <news:title>Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912327335-elevra-lithium-announces-purchase-of-moblan-offtake-rights</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:05:00+00:00</news:publication_date>
        <news:title>Elevra Lithium Announces Purchase of Moblan Offtake Rights</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f5758a63-2477-4360-8e0d-d2d722cda136/small/elevra-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912327370-sellas-life-sciences-reports-first-quarter-2026-financial-results-and-provides-corporate-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:05:00+00:00</news:publication_date>
        <news:title>SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4ff07596-ddcc-4df5-be2f-e31a35217739/small/sellas-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912327423-rani-therapeutics-to-participate-in-the-h-c-wainwright-annual-bioconnect-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:05:00+00:00</news:publication_date>
        <news:title>Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8ce7774c-3696-4aa1-8bcd-413805f0a642/small/rani-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912327452-damora-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:05:00+00:00</news:publication_date>
        <news:title>Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/547722cf-495b-4464-97a9-35bea3fa5d15/small/damora-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912327359-kyverna-therapeutics-announces-initiation-of-rolling-sps-bla-submission-and-reports-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:02:00+00:00</news:publication_date>
        <news:title>Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912327228-inhibikase-therapeutics-announces-first-quarter-2026-financial-results-and-highlights-recent-activity</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:01:00+00:00</news:publication_date>
        <news:title>Inhibikase Therapeutics Announces First Quarter 2026 Financial Results and Highlights Recent Activity</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/32b8d8bc-ebf8-43c0-866a-6613b22263b1/small/ikt-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912327713-maze-therapeutics-reports-first-quarter-2026-financial-results-and-recent-highlights</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T20:01:00+00:00</news:publication_date>
        <news:title>Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/20759f53-8fbe-4af8-9fc1-3a4a4ac5c195/small/lol-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912263026-nevgold-announces-closing-of-upsized-42m-brokered-private-placement-financing</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T13:50:30+00:00</news:publication_date>
        <news:title>NEVGOLD ANNOUNCES CLOSING OF UPSIZED $42M BROKERED PRIVATE PLACEMENT FINANCING</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/305d6e29-37f9-45b1-9a2e-4e5d0bd82d5a/small/nevgold-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244503-agios-submits-snda-to-fda-for-u-s-accelerated-approval-of-mitapivat-in-sickle-cell-disease</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T13:31:00+00:00</news:publication_date>
        <news:title>Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244194-cogent-biosciences-announces-multiple-presentations-at-the-european-hematology-association-eha-2026-congress</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T13:30:00+00:00</news:publication_date>
        <news:title>Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244522-agios-to-present-new-data-at-eha-2026-reinforcing-the-significant-therapeutic-impact-of-mitapivat-across-multiple-rare-hemolytic-anemias</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T13:30:00+00:00</news:publication_date>
        <news:title>Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244899-ajax-therapeutics-announces-oral-presentation-of-clinical-results-from-ajx-101-a-phase-i-study-of-aj1-11095-a-first-in-class-type-ii-jak2-inhibitor</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T13:30:00+00:00</news:publication_date>
        <news:title>Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4a1616ad-5fbb-4df2-8270-094f5294c667/small/ajax-gradient-logo-rgb-large-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912245006-cellectis-to-present-clinical-data-on-lasme-cel-and-eti-cel-at-eha-2026-annual-congress</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T13:30:00+00:00</news:publication_date>
        <news:title>Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912245010-cellectis-pr-sentera-des-donn-es-cliniques-sur-lasm-cel-et-ti-cel-au-congr-s-annuel-de-l-eha-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T13:30:00+00:00</news:publication_date>
        <news:title>Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912245200-globex-enters-option-agreement-on-its-ramp-maude-lake-gold-property-in-ontario</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:41:49+00:00</news:publication_date>
        <news:title>Globex Enters Option Agreement on its Ramp/Maude Lake Gold Property in Ontario</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/838965b5-a9ed-43e8-bee2-4b65d3d625ab/medium/exhibit-1-ramp-maude-lake-property-geology-and-mineralizatio.gif</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912245065-clearmind-medicine-reaches-important-clinical-milestone-20-participants-now-treated-in-ongoing-phase-i-iia-trial-of-cmnd-100-for-alcohol-use-disorder</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:41:00+00:00</news:publication_date>
        <news:title>Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244725-orchestra-biomed-targeting-backbeat-trial-enrollment-completion-by-end-of-q3-2026-and-data-presentation-in-q2-2027</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:30:00+00:00</news:publication_date>
        <news:title>Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244831-oncotelic-therapeutics-inc-otcqb-otlc-proprietary-n2b-system-may-offer-key-to-unlocking-next-gen-therapies</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:30:00+00:00</news:publication_date>
        <news:title>Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244950-surenano-science-ltd-cse-sure-otcqb-surnf-advancing-a-differentiated-next-gen-glp-1-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:30:00+00:00</news:publication_date>
        <news:title>SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4e983dfa-f169-46a5-ba21-ed1d05a90830/small/surenano-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912245047-crml-set-to-become-the-market-leader-for-hafnium-production-and-supply-security-taking-away-china-s-current-75-market-share</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:30:00+00:00</news:publication_date>
        <news:title>CRML Set to Become the Market Leader for Hafnium Production and Supply Security Taking Away China&#39;s Current 75% Market Share</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d3ef28b7-e06b-4790-8e8a-e2b8c5025464/medium/global-hafnium-market.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244347-rhythm-pharmaceuticals-announces-new-data-presentations-at-the-2026-european-congress-of-endocrinology</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:00:00+00:00</news:publication_date>
        <news:title>Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244420-cerevance-completes-enrollment-in-pivotal-phase-3-parkinson-s-disease-trial-and-closes-oversubscribed-20-million-series-c-to-extend-runway-into-2027</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:00:00+00:00</news:publication_date>
        <news:title>Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7b8bba27-38bb-484c-afef-fc5a539ec4e5/small/cerevance-logo-px-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244655-lyell-immunopharma-announces-participation-in-may-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:00:00+00:00</news:publication_date>
        <news:title>Lyell Immunopharma Announces Participation in May Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fa4a7bb1-f8ea-45e7-ba51-37077689a4fb/small/lyell-branding-color-rgb-102918a-copy-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244676-trident-resources-commences-regional-structural-analysis-of-its-la-ronge-gold-belt-properties-in-saskatchewan-with-srk-consulting</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:00:00+00:00</news:publication_date>
        <news:title>Trident Resources Commences Regional Structural Analysis of its La Ronge Gold Belt Properties in Saskatchewan with SRK Consulting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0600ebb6-8df0-4289-b4f8-ab2eb5d3044b/small/trident-resources-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244826-ataibeckley-reports-first-quarter-2026-financial-results-and-provides-program-and-business-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:00:00+00:00</news:publication_date>
        <news:title>AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cea08bf4-0562-45ed-af5c-c9376c48a6eb/small/ataibeckley-horizontal-2color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912244894-sonoro-gold-announces-letters-of-intent-to-acquire-adjacent-mineral-concessions-to-further-expand-the-cerro-caliche-gold-project</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T12:00:00+00:00</news:publication_date>
        <news:title>SONORO GOLD ANNOUNCES LETTERS OF INTENT TO ACQUIRE ADJACENT MINERAL CONCESSIONS TO FURTHER EXPAND THE  CERRO CALICHE GOLD PROJECT</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c560d7b7-e7aa-4c99-a950-2bed3c5fa9ce/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912245028-fx-junction-releases-report-on-top-5-cases-of-social-media-impact-on-stock-markets</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:58:31+00:00</news:publication_date>
        <news:title>FX Junction Releases Report on Top 5 Cases of Social Media Impact on Stock Markets</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/80648ae8-0f11-42cc-8475-fa818ca816a9/medium/fx-junction-releases-report-on-top-5-cases-of-social-media-i.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225374-midland-exploration-completes-a-first-tranche-of-2-2-million-private-placement</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:30:00+00:00</news:publication_date>
        <news:title>Midland Exploration Completes a First Tranche of $2.2 Million Private Placement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3e4ce21f-9796-45f4-b210-a629e007f63a/small/midland-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225377-exploration-midland-compl-te-une-premi-re-tranche-de-2-2-millions-dans-le-cadre-d-un-placement-priv</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:30:00+00:00</news:publication_date>
        <news:title>Exploration Midland complète une première tranche de 2,2 millions $ dans le cadre d’un placement privé</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3e4ce21f-9796-45f4-b210-a629e007f63a/small/midland-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225444-mereo-biopharma-reports-first-quarter-2026-financial-results-and-provides-corporate-updates</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:30:00+00:00</news:publication_date>
        <news:title>Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d8cb3e79-0641-4cca-8687-15281f1437be/small/mereo-logo-full-colour-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225557-bridgebio-submits-nda-to-fda-for-encaleret-for-individuals-living-with-adh1</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:30:00+00:00</news:publication_date>
        <news:title>BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225584-niob-seigneurie-step-out-drilling-confirms-pegmatite-system-extends-laterally-over-1-5-kilometres</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:30:00+00:00</news:publication_date>
        <news:title>NIOB Seigneurie Step-out Drilling Confirms Pegmatite System Extends Laterally Over 1.5 kilometres</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/14cfbd26-7d34-4ee7-8f29-6d515821e186/small/north-american-niobium-and-critical-minerals-logo-251130-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225617-achieve-life-sciences-strengthens-board-and-commercial-leadership-with-three-senior-appointments-from-team-previously-at-verona-pharma</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:05:00+00:00</news:publication_date>
        <news:title>Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1026e030-275c-4391-8f9a-65c5c1ec7b88/small/achieve-logo-717x800px-2-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225676-arvinas-reports-first-quarter-2026-financial-results-and-provides-corporate-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:05:00+00:00</news:publication_date>
        <news:title>Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/563780a0-f8d9-4e37-8665-b622ef2caa5b/small/arvinas-logoart-lg-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225324-prelude-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:01:00+00:00</news:publication_date>
        <news:title>Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cab62748-b61a-42cb-b552-b0c6c91c4e83/small/ptx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225276-proqr-announces-first-quarter-2026-operating-and-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:00:00+00:00</news:publication_date>
        <news:title>ProQR Announces First Quarter 2026 Operating and Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225344-foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-may</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:00:00+00:00</news:publication_date>
        <news:title>Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225364-acumen-pharmaceuticals-reports-first-quarter-2026-financial-results-and-business-highlights</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:00:00+00:00</news:publication_date>
        <news:title>Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225393-nexgold-initiates-vtem-and-falcon-gravity-airborne-geophysical-surveys-at-goldboro-and-announces-appointment-of-new-board-member</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:00:00+00:00</news:publication_date>
        <news:title>NexGold Initiates VTEM™ and FALCON® Gravity Airborne Geophysical Surveys at Goldboro and Announces Appointment of New Board Member</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/134e6499-94bb-4165-91aa-9649c6d45fcb/small/nexgold-logo-gold-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225520-medicenna-and-fondazione-melanoma-onlus-announce-first-patient-dosed-in-the-neo-cyt-study-of-mdna11-in-neoadjuvant-melanoma</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:00:00+00:00</news:publication_date>
        <news:title>Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225615-achieve-life-sciences-reports-first-quarter-2026-financial-results-and-provides-business-updates</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:00:00+00:00</news:publication_date>
        <news:title>Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1026e030-275c-4391-8f9a-65c5c1ec7b88/small/achieve-logo-717x800px-2-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225672-arvinas-and-pfizer-enter-into-a-transaction-with-rigel-pharmaceuticals-for-the-exclusive-global-rights-of-veppanu-vepdegestrant</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T11:00:00+00:00</news:publication_date>
        <news:title>Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/563780a0-f8d9-4e37-8665-b622ef2caa5b/small/arvinas-logoart-lg-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912225284-lithium-argentina-reports-first-quarter-2026-results</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T10:34:13+00:00</news:publication_date>
        <news:title>Lithium Argentina Reports First Quarter 2026 Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/M2ZhOTk0ZjEtY2UxYy00YTRmLTgyYzgtMmUxOTI1ZWNhYmRkLTEzMTg3NDUtMjAyNi0wNS0xMi1lbg==/tiny/Lithium-Argentina-AG.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912206928-korea-university-s-2026-ai-blockchain-ideathon-successfully-concludes-sponsored-by-mexc-ventures</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T10:00:00+00:00</news:publication_date>
        <news:title>Korea University&#39;s 2026 AI &amp; Blockchain Ideathon Successfully Concludes, Sponsored by MEXC Ventures</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d6d0df58-32b6-48f0-ad29-5eb915576a6a/medium/korea-university-s-2026-ai-blockchain-ideathon-successfully.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912062734-brazilian-machinery-industry-targets-expansion-in-african-agribusiness-with-presence-at-nampo-show-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-11T21:40:14+00:00</news:publication_date>
        <news:title>Brazilian machinery industry targets expansion in African agribusiness with presence at NAMPO Show 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24853440-brazil-at-nampo-1200x1600.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/910877017-baraka-foundation-canada-launches-new-website-to-expand-digital-reach-and-donor-engagement</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-11T21:38:41+00:00</news:publication_date>
        <news:title>Baraka Foundation Canada Launches New Website to Expand Digital Reach and Donor Engagement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24849367-bf1-800x600.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912206989-mexc-commits-to-500m-guardian-fund-expansion-acquires-1-000-btc-to-strengthen-user-protection</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T09:00:00+00:00</news:publication_date>
        <news:title>MEXC Commits to $500M Guardian Fund Expansion, Acquires 1,000 BTC to Strengthen User Protection</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d145d16d-01e6-486c-9035-aebaefad001d/medium/mexc-commits-to-500m-guardian-fund-expansion-acquires-1-000.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912192680-keine-teilnahmegeb-hr-600-000-teilen-zoomex-startet-den-weltweit-ersten-trading-wettbewerb-ohne-kapitaleinsatz-lassen-sie-ihr-k-nnen-ihr-einziges</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T08:08:31+00:00</news:publication_date>
        <news:title>Keine Teilnahmegebühr, 600.000 $ teilen! Zoomex startet den weltweit ersten Trading-Wettbewerb ohne Kapitaleinsatz: Lassen Sie Ihr Können Ihr einziges Kapital sein</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/46954337-7aef-443b-9b71-7e3acb2510dd/medium/0-cost-trading-wettbewerb.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912192683-no-entry-fee-share-600-000-zoomex-launches-the-worfld-s-first-zero-cost-trading-competition-let-skill-be-your-only-asset</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T08:08:31+00:00</news:publication_date>
        <news:title>No Entry Fee, Share $600,000! Zoomex Launches the WorFld’s First Zero-Cost Trading Competition: Let Skill Be Your Only Asset</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/46954337-7aef-443b-9b71-7e3acb2510dd/medium/zero-cost-trading-competition.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912192688-sin-cuota-de-inscripci-n-comparte-600-000-zoomex-lanza-la-primera-competici-n-de-trading-a-coste-cero-del-mundo-que-tu-talento-sea-tu-nico</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T08:08:31+00:00</news:publication_date>
        <news:title>¡Sin cuota de inscripción, comparte 600.000 $! Zoomex lanza la primera competición de trading a coste cero del mundo: que tu talento sea tu único active</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/46954337-7aef-443b-9b71-7e3acb2510dd/medium/0-concurso-de-trading-sin-costos.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912192693-pas-de-frais-d-inscription-partagez-600-000-zoomex-lance-la-premi-re-comp-tition-de-trading-co-t-z-ro-au-monde-que-votre-talent-soit-votre</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T08:08:31+00:00</news:publication_date>
        <news:title>Pas de frais d&#39;inscription, partagez 600 000 $ ! Zoomex lance la première compétition de trading à coût zéro au monde : que votre talent soit votre seul atout</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/46954337-7aef-443b-9b71-7e3acb2510dd/medium/0-cout-competition-de-trading.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912192666-vicentra-announces-commercial-launch-of-new-smartphone-controlled-kaleido-automated-insulin-delivery-patch-pump-system</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T07:30:00+00:00</news:publication_date>
        <news:title>ViCentra Announces Commercial Launch of New Smartphone-Controlled Kaleido Automated Insulin Delivery Patch Pump System</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/97cc2ebe-8f0d-4051-aca4-6350b6043071/small/vicentra-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912177621-enterome-presents-phase-2-indolent-non-hodgkin-lymphoma-data-at-eha-showing-eo2463-induces-b-cell-target-specific-cd8-t-cell-expansion-correlating</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T06:30:00+00:00</news:publication_date>
        <news:title>Enterome presents Phase 2 indolent non-Hodgkin lymphoma data at EHA showing EO2463 induces B cell target-specific CD8 T-cell expansion correlating with clinical outcomes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/e04b919f-9b3c-4d80-af54-707d3fa48216/small/enterome-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912177603-infex-therapeutics-secures-4-3-million-funding-to-advance-anti-infective-pipeline-targeting-drug-resistant-infections</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T06:00:00+00:00</news:publication_date>
        <news:title>Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/7e6719ab-feb1-4eb3-93c1-acca0cc4a3a1/small/infex-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912143914-elevra-lithium-s-updated-nal-expansion-scoping-study-defines-faster-growth-and-lower-costs</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-12T03:21:49+00:00</news:publication_date>
        <news:title>Elevra Lithium’s Updated NAL Expansion Scoping Study Defines Faster Growth and Lower Costs</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f5758a63-2477-4360-8e0d-d2d722cda136/small/elevra-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912071498-macrogenics-to-sell-gmp-manufacturing-operations-to-bora-pharmaceuticals</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-11T21:20:43+00:00</news:publication_date>
        <news:title>MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.timesreporterafrica.com/article/912071398-skyharbour-closes-5-25-million-private-placement-of-flow-through-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Times Reporter of Africa</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-11T21:00:00+00:00</news:publication_date>
        <news:title>Skyharbour Closes $5.25 Million Private Placement of Flow-Through Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/16423a4e-ffa9-4806-9254-b16d8f3ce465/small/skyharbour-resources-ltd-logo.jpg</image:loc>
        </image:image>
    </url>
</urlset>
